Results 131 to 140 of about 29,486 (214)

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial [PDF]

, 2023
Dean Follmann, Holly Janes, Eric Chun‐Pu Chu, Lakshmi Jayashankar, Christos J. Petropoulos, Leonid Serebryannyy, Robin Carroll, Naz Jean-Baptiste, Sandeep Narpala, Bob C. Lin, Adrian B. McDermott, Richard M. Novak, Daniel S. Graciaa, Stephanie Rolsma, Craig A. Magaret, Nicole A. Doria‐Rose, Lawrence Corey, Kathleen M. Neuzil, Rolando Pajón, Jacqueline M. Miller, Rubén O. Donis, Richard A. Koup, Lindsey R. Baden, Hana M. El Sahly   +23 more
openalex   +1 more source

IgG antibody responses to SARS-CoV-2 vaccination in Manitoba, Canada [PDF]

Understanding variables that influence antibody responses to SARS-CoV-2 vaccination within a population can provide valuable information on future vaccination strategies.
Martens, Brielle
core   +1 more source

Acute Myocarditis After COVID-19 Vaccination with mRNA-1273 in a Patient with Former SARS-CoV-2 Infection [PDF]

, 2021
Tiến Dũng Nguyễn, Gerhard Mall, Julian Westphal, Oliver Weingärtner, Sven Möbius‐Winkler, P. Christian Schulze   +5 more
openalex   +1 more source

Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework [PDF]

INTRODUCTION:The mRNA vaccines mRNA-1273 and BNT162b2 demonstrated high efficacy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in phase 3 clinical trials, including among older adults.
Bausch-Jurken, MT, Beck, E, Green, N, Haeussler, K, Kavikondala, S, Malmenäs, M, Mishra, NK, Nassim, M, Sharma, P, Van de Velde, N, Wang, X   +10 more
core  

Replication Data for Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain

, 2022
Gabriel Reina
openalex   +1 more source

Immunogenicity of the mRNA-1273 COVID-19 Vaccine in Patients With Inborn Errors of Immunity

, 2022
Leanne P. M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, Godelieve J. de Bree, Judith Potjewijd, Abraham Rutgers, Hetty Jolink, Frank L. van de Veerdonk, Eric C. M. Van Gorp, Faye de Wilt, Susanne Bogers, Lennert Gommers, Daryl Geers, Anke H. W. Bruns, Helen L. Leavis, Jelle van Haga, Bregtje A. Lemkes, Annelou van Veen, Suzanne de Kruijff, Pieter van Paassen, Karina de Leeuw, Annick van der Ven, Petra Verbeek, Annelies van Wengen, Sandra M. Arend, Anja Ruten-Budde, Marianne van der Ent, Martin van Hagen, Rogier W. Sanders, Marloes Grobben, Karlijn van der Straten, Judith A. Burger, Meliawati Poniman, Marit J. van Gils, Rory D. de Vries, Virgil A. S. H. Dalm   +35 more
openalex   +1 more source

mRNA-1273/rituximab [PDF]

Reactions Weekly, 2021
openaire   +1 more source

Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients

, 2022
Aitor Odriozola Herrán, María Del Barrio, Antonio Cuadrado, José Ignacio Fortea, Lidia Amigo, David San Segundo Arribas, María Paz Rodriguez‐Cundin, María Emilia Rebollo, Roberto Fernández, Federico Castillo, María Achalandabaso, Juan Echeverri, Juan Carlos Rodríguez-San Juan, Marcos López‐Hoyos, Juan Carlos Rodríguez Duque, Álex García Tellado, Javier Crespo, Emilio Fábrega   +17 more
openalex   +2 more sources

Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis [PDF]

, 2022
Frank Scheuermeyer, Jeff Yoo, Michael Greene, Shannon O’Donnell   +3 more
openalex   +1 more source

mRNA-1273/tozinameran [PDF]

Reactions Weekly, 2022
openaire   +2 more sources